Welcome to CDC stacks | The National Amyotrophic Lateral Sclerosis (ALS) Registry - 33911 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The National Amyotrophic Lateral Sclerosis (ALS) Registry
  • Published Date:
    2012 Jul-Aug
  • Source:
    J Environ Health. 75(1):28-30.
Filetype[PDF-41.98 KB]


Details:
No Related Documents.
You May Also Like:
  1. CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions
    Personal Author:
    Mehta, Paul; Horton, D. Kevin; Kasarskis, Edward J.; Tessaro, Ed; Eisenberg, M. Shira; Laird, Susan; Iskander, John;
    Published:
    Dec 22 2017
    Source:
    MMWR Morb Mortal Wkly Rep. 66(50):1379-1382.
    Description:
    Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a rapidly progressive fatal neurologic disease. Currently, there is no cure for ALS and the available treatments only extend life by an average of a few months. The major...
    File Type:
    Filetype[PDF - 107.88 KB]
  2. Prevalence of amyotrophic lateral sclerosis — United States, 2012–2013
    Personal Author:
    Mehta, Paul; Kaye, Wendy; Bryan, Leah; Larson, Theodore C.; Copeland, Timothy; Wu, Jennife; Muravov, Oleg; Horton, Kevin;
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    August 5, 2016
    Series:
    MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries; v. 65, no. SS-8
    Description:
    Problem/Condition: Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a progressive and fatal neuromuscular disease for which no cure or viable treatment has been identified. ALS, like most noncommunicable diseases, is ...
    File Type:
    Filetype[PDF - 449.78 KB]
  3. The National Amyotrophic Lateral Sclerosis (ALS) Biorepository
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    1/11/2017
    Description:
    The National ALS Biorepository (Biorepository) is part of the National ALS Registry. It will include samples from persons with ALS (PALS) who are enrolled in the National ALS Registry. : The National ALS Biorepository differs from other biorepositori...
    File Type:
    Filetype[PDF - 105.58 KB]
  4. Prevalence of Amyotrophic Lateral Sclerosis — United States, 2015
    Personal Author:
    Mehta, Paul; Kaye, Wendy; Raymond, Jaime; Punjani, Reshma; Larson, Theodore; Cohen, Jessica; Muravov, Oleg; Horton, Kevin;
    Published:
    Nov 23 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(46):1285-1289
    Description:
    Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a progressive and fatal neuromuscular disease; the majority of ALS patients die within 2-5 years of receiving a diagnosis (1). Familial ALS, a hereditary form of the dise...
    File Type:
    Filetype[PDF - 166.88 KB]
  5. Prevalence of Amyotrophic Lateral Sclerosis — United States, 2014
    Personal Author:
    Mehta, Paul; Kaye, Wendy; Raymond, Jaime; Wu, Ruoming; Larson, Theodore; Punjani, Reshma; Heller, Daniel; Cohen, Jessica; Peters, Tracy; Muravov, Oleg; Horton, Kevin;
    Published:
    Feb 23 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(7):216-218.
    Description:
    Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a progressive and fatal neuromuscular disease; the majority of ALS patients die within 2-5 years of receiving a diagnosis (1). Familial ALS, a hereditary form of the dise...
    File Type:
    Filetype[PDF - 101.78 KB]